Literature DB >> 9017958

Male breast cancer in patients with a familial history of breast cancer.

S Akashi-Tanaka1, T Fukutomi, A Fukami, T Fujiki.   

Abstract

We describe herein the clinical characteristics of five male breast carcinoma (MBC) patients with a familial history of breast carcinoma (FHBC). Four of these patients suffered from multiple primary cancers, being gastric and prostate cancer in 1, gastric cancer in 1, and asynchronous bilateral breast cancers in 2. The average age of these patients at diagnosis was not lower than that of MBC patients with no such familial history. The aggregation of cancer in these families had three prominent characteristics: (1) The families included women with early-onset breast cancers which had occurred at the ages of 38, 38, and 35 years, respectively, and/or early-onset uterine cancer which had occurred at the age of 35 years. (2) The incidence of multiple primary cancers was significantly higher in the siblings of MBC patients with a FHBC than without. (3) There were many cancers in hormone-related organs in two families.

Entities:  

Mesh:

Year:  1996        PMID: 9017958     DOI: 10.1007/bf00309956

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  Low urinary estrogen glucuronides in women at risk for familial breast cancer.

Authors:  J Fishman; D K Fukushima; J O'Connor; H T Lynch
Journal:  Science       Date:  1979-06-08       Impact factor: 47.728

2.  [The breast cancer-prone family: clinical study of familial breast cancer].

Authors:  T Nomizu; R Abe
Journal:  Gan No Rinsho       Date:  1987-04

3.  Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer.

Authors:  A Arason; R B Barkardóttir; V Egilsson
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

4.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

5.  Familial breast cancer in a population-based series.

Authors:  R Ottman; M C Pike; M C King; J T Casagrande; B E Henderson
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

6.  Bilateral malignant lymphoma of the breast in patients with a familial history of cancer: a report of three cases.

Authors:  H Saito; T Fukutomi; H Yamamoto; T Nanasawa; H Ohtani; H Tsuda
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  A clinicopathological analysis of breast cancer in patients with a family history.

Authors:  T Fukutomi; Y Kobayashi; T Nanasawa; H Yamamoto; H Tsuda
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Germline mutation of BRCA1 in Japanese breast cancer families.

Authors:  R Inoue; T Fukutomi; T Ushijima; Y Matsumoto; T Sugimura; M Nagao
Journal:  Cancer Res       Date:  1995-08-15       Impact factor: 12.701

9.  Familial breast cancer risks. Effects of prostate and other cancers.

Authors:  D E Anderson; M D Badzioch
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

10.  Linkage analysis of BRCA1 in Japanese breast cancer families.

Authors:  R Inoue; T Fukutomi; T Ushijima; Y Matsumoto; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-12
View more
  2 in total

1.  Synchronous bilateral breast carcinoma in a 50-year-old man with 45,X/46,XY mosaic karyotype: report of a case.

Authors:  Gianluca Franceschini; Pierfrancesco D'Alba; Melania Costantini; Andrea Magistrelli; Paolo Belli; Antonino Mulè; Claudio Coco; Aurelio Picciocchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Metachronous or synchronous male breast and prostate cancers a duality to lookout for.

Authors:  Alain Mwamba Mukendi; Eunice Van Den Berg; Sugeshnee Pather; Rushen Siva Padayachee
Journal:  F1000Res       Date:  2018-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.